Abstract
Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 448-451 |
| Number of pages | 4 |
| Journal | American Journal of Clinical Oncology: Cancer Clinical Trials |
| Volume | 17 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jan 1 1994 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?'. Together they form a unique fingerprint.
Cite this
Feun, L. G., Savaraj, N., Benedetto, P., Waldman, S., Collier, M., & Clendennin, N. J. (1994). Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy? American Journal of Clinical Oncology: Cancer Clinical Trials, 17(5), 448-451. https://doi.org/10.1097/00000421-199410000-00019